(Q40869143)

24 September 2017

1 reference

title

Optimisation of cyclophosphamide therapy in systemic vasculitis (English)

1 reference

24 September 2017

Raashid Ahmed Luqmani

series ordinal

3

1 reference

24 September 2017

Richmond R

1

1 reference

PubMed ID

9474474

24 September 2017

McMillan TW

series ordinal

2

1 reference

24 September 2017

1 January 1998

1 reference

Clinical Pharmacokinetics

24 September 2017

1 reference

24 September 2017

34

1 reference

24 September 2017

79-90

1 reference

24 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199834010-00004

24 September 2017

0 references

cites work

Stem cell transplantation for severe autoimmune diseases: new proposals but still unanswered questions

1 reference

12 December 2020

IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy

1 reference

12 December 2020

Apparent cure of rheumatoid arthritis by bone marrow transplantation.

1 reference

12 December 2020

Glomerulonephritis: diagnosis and treatment

1 reference

12 December 2020

Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies

1 reference

12 December 2020

Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis

1 reference

12 December 2020

Pooled intravenous immunoglobulin in the management of systemic vasculitis

1 reference

12 December 2020

Clinical Pharmacokinetics of Cyclophosphamide

1 reference

12 December 2020

Reversal of progressive necrotizing vasculitis with intravenous pulse cyclophosphamide and methylprednisolone

1 reference

12 December 2020

VITAL (Vasculitis Integrated Assessment Log) assessment of vasculitis

1 reference

12 December 2020

Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy

1 reference

12 December 2020

Respiratory failure in Wegener's granulomatosis: response to pulse intravenous methylprednisolone and cyclophosphamide.

1 reference

12 December 2020

Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative St

1 reference

12 December 2020

Therapy of vasculitis

1 reference

12 December 2020

Programmed cell death in the pathogenesis of murine IDDM: resistance to apoptosis induced in lymphocytes by cyclophosphamide

1 reference

12 December 2020

Cyclophosphamide Therapy of Severe Systemic Necrotizing Vasculitis

1 reference

12 December 2020

Effect of liver failure on the pharmacokinetics of cyclophosphamide

1 reference

12 December 2020

Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide

1 reference

12 December 2020

Regression of adjuvant-induced arthritis in rats following bone marrow transplantation

1 reference

12 December 2020

Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation.

1 reference

12 December 2020

Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only

1 reference

12 December 2020

Relapses in patients with a systemic vasculitis

1 reference

12 December 2020

Plasma pharmacokinetics of cyclophosphamide and its cytotoxic metabolites after intravenous versus oral administration in a randomized, crossover trial

1 reference

12 December 2020

Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides

1 reference

12 December 2020

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

1 reference

12 December 2020

Pulse cyclophosphamide therapy in Wegener's granulomatosis: a pilot study

1 reference

12 December 2020

Autoimmune disease. A problem of defective apoptosis

1 reference

12 December 2020

Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic diseases

1 reference

12 December 2020

Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients.

1 reference

12 December 2020

Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT

1 reference

12 December 2020

Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis

1 reference

12 December 2020

Menstrual disorders in girls with systemic lupus erythematosus treated with cyclophosphamide.

1 reference

12 December 2020

Intravenous immunoglobulin as sole therapy for systemic vasculitis

1 reference

12 December 2020

Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes

1 reference

12 December 2020

Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis

1 reference

12 December 2020

Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis

1 reference

12 December 2020

Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis

1 reference

12 December 2020

New treatment strategies for systemic vasculitis: the role of intravenous immune globulin therapy

1 reference

12 December 2020

Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis

1 reference

12 December 2020

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

1 reference

12 December 2020

Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia.

1 reference

12 December 2020

Cyclophosphamide Therapy in Wegener's Granulomatosis

1 reference

12 December 2020

Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations

1 reference

12 December 2020

Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group

1 reference

12 December 2020

The interaction of endothelial cells with inflammatory cells in vasculitis

1 reference

12 December 2020

Intractable diseases and bone marrow transplantation

1 reference

12 December 2020

1 reference

12 December 2020

Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospect

1 reference

12 December 2020

Infectious complications of cyclophosphamide treatment for vasculitis

1 reference

12 December 2020

The Use of Alkylating Agents in the Treatment of Wegener's Granulomatosis

1 reference

12 December 2020

Immune ablation followed by allogeneic or autologous bone marrow transplantation: a new treatment for severe autoimmune diseases?

1 reference

12 December 2020

Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis

1 reference

12 December 2020

Induction of apoptosis in murine tumors by cyclophosphamide

1 reference

12 December 2020

New developments in the treatment of systemic vasculitis.

1 reference

12 December 2020

Clinical infections, antibiotics and immunosuppression: a puzzling relationship

1 reference

12 December 2020

Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort

1 reference

12 December 2020

Bone Marrow Transplantation in Patients with Gold-Induced Marrow Aplasia

1 reference

12 December 2020

Cyclophosphamide-induced bladder toxicity in wegener's granulomatosis

1 reference

12 December 2020

Cyclophosphamide pulses in the treatment of rheumatic diseases: an update

1 reference

12 December 2020

Cardiotoxicity Associated With High-Dose Cyclophosphamide Therapy

1 reference

12 December 2020

Immunosuppressive and corticosteroid therapy of polyarteritis nodosa

1 reference

12 December 2020

Endothelial cell activation in patients with systemic vasculitis

1 reference

12 December 2020

Hemorrhagic cystitis: a review

1 reference

12 December 2020

Stem cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases.

1 reference

12 December 2020

Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis)

1 reference

12 December 2020

Clinical pharmacology of cyclophosphamide

1 reference

12 December 2020

Selective mitomycin C and cyclophosphamide induction of apoptosis in differentiating B lymphocytes compared to T lymphocytes in vivo

1 reference

12 December 2020

Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation

1 reference

12 December 2020

Clinical pharmacokinetics of cyclophosphamide

1 reference

12 December 2020

Limited plasmapheresis in rheumatoid arthritis with vasculitis

1 reference

12 December 2020

Hematopoietic stem cell transplantation in rheumatic diseases other than systemic sclerosis and systemic lupus erythematosus

1 reference

12 December 2020

Immunologic tissue injury mediated by neutrophilic leukocytes.

1 reference

12 December 2020

Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor

1 reference

12 December 2020

Pharmacokinetics of cyclophosphamide in patients with systemic necrotizing angiitis

1 reference

12 December 2020

BMT in experimental autoimmune diseases.

1 reference

12 December 2020

Acute nonlymphocytic leukemia following short-term, intermittent, intravenous cyclophosphamide treatment of lupus nephritis

1 reference

12 December 2020

Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes

1 reference

12 December 2020

Wegener's granulomatosis: studies in eighteen patients and a review of the literature

1 reference

12 December 2020

Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis.

1 reference

12 December 2020

Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years

1 reference

12 December 2020

Plasma exchange in rheumatoid vasculitis

1 reference

12 December 2020

Role of apoptosis in mediating phosphoramide mustard-induced rat embryo malformations in vitro

1 reference

12 December 2020

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

1 reference

12 December 2020

Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT

1 reference

12 December 2020

Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide

1 reference

12 December 2020

Polymorphonuclear leukocytes in immunologic reactions. The destruction of vascular basement membrane in vivo and in vitro

1 reference

12 December 2020

European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials EUROPEAN COMMUNITY STUDY GROUP ON CLINICAL TRIALS IN SYSTEMIC VASCULITIS ECSYSVASTRIAL (BMHl-Cr93-1078)

1 reference

12 December 2020

Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients

1 reference

12 December 2020

Long-term follow-up study of periarteritis nodosa.

1 reference

12 December 2020

Apoptosis in the repair process of experimental proliferative glomerulonephritis

1 reference

12 December 2020

Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges

1 reference

12 December 2020

Induction of apoptosis and cathepsin D in limbs exposed in vitro to an activated analog of cyclophosphamide

1 reference

12 December 2020

Classification and epidemiology of systemic vasculitis

1 reference

12 December 2020

Wegener Granulomatosis: An Analysis of 158 Patients

1 reference

12 December 2020

High-dose cyclophosphamide-induced myocardial damage during BMT: assessment by positron emission tomography

1 reference

12 December 2020

Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin

1 reference

12 December 2020

Cyclophosphamide pulse therapy in Wegener's granulomatosis

1 reference

12 December 2020

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

1 reference

12 December 2020

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy

1 reference

12 December 2020

10.2165/00003088-199834010-00004

Identifiers

DOI

1 reference

PubMed ID

9474474

Dimensions Publication ID

24 September 2017

0 references

1 reference

PubMed ID

9474474